InsightRP2—An Interdisciplinary Approach Toward Therapy Development in RP2 -Associated Retinopathy
Human Gene Therapy · 01.12.2026 · 37 (23-24) · 1079-1085
DOI: 10.1177/10430342261480906 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Gene Therapy, online erschienen am 14.09.2026. Verfasst von Nina Bögershausen und 18 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Human Genetics, University Medical Center Göttingen, Göttingen, Germany. Hauptthemen laut MEDLINE: Genetic Therapy, Membrane Proteins, Retinitis Pigmentosa. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Advancing the development of specific gene therapies for rare genetic eye disorders is a major challenge in modern translational vision research. It requires integrated clinical, molecular, mechanistic, and regulatory expertise, yet these aspects are often addressed in isolation. Combining complementary skills, knowledge, and expertise within an integrated, highly interactive research framework has the capacity to drive and advance therapeutic development. Moreover, early-stage involvement of patients and targeted clinical observation, alongside molecular and therapeutic research, potentially enable clinical trial readiness and support the translation of preclinical therapeutic innovations into clinical care. In this Perspective article, we present the InsightRP2 framework, an integrated translational strategy that incorporates clinical data, artificial intelligence–supported imaging analysis, experimental disease modeling, and adeno-associated virus design with the aim to facilitate the development of a targeted gene therapy for RP2 -associated retinitis pigmentosa.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Human Genetics, University Medical Center Göttingen, Göttingen, Germany.
- Stem Cell Unit, Clinic for Cardiology and Pneumology, University Medical Center Göttingen, Göttingen, Germany.
- Department of Ophthalmology, University Medical Center Göttingen, Göttingen, Germany.
- Department of Ophthalmology, LMU University Hospital, LMU Munich, Germany.
- Institute for Genomic Statistics and Bioinformatics, University Hospital Bonn, Bonn, Germany.
- German Center for Child and Adolescent Health (DZKJ), Partner Site Göttingen, Göttingen, Germany.
ORCID-Profile: Nina Bögershausen, Patricia Döring, Behnam Javanmardi, Hildegard Büning
Förderung
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Bögershausen, N., Yigit, G., Fedorenko, A., Bayati, R., Döring, P., Gerhardt, M., Strohmeyer, C., Gutiérrez-Gutiérrez, O., Javanmardi, B., Gaubert, M., Kaygusuz, E., Krawitz, P., Ueffing, M., Hoerauf, H., Feltgen, N., Michalakis, S., Büning, H., Cyganek, L., & Wollnik, B. (2026). InsightRP2—An Interdisciplinary Approach Toward Therapy Development in RP2 -Associated Retinopathy. Human Gene Therapy, 37(23-24), 1079-1085. https://doi.org/10.1177/10430342261480906
Vancouver
Bögershausen N, Yigit G, Fedorenko A, Bayati R, Döring P, Gerhardt M, et al. InsightRP2—An Interdisciplinary Approach Toward Therapy Development in RP2 -Associated Retinopathy. Human Gene Therapy. 2026;37(23-24):1079-1085. doi:10.1177/10430342261480906
BibTeX
@article{Bgershausen2026,
author = {Bögershausen, Nina and Yigit, Gökhan and Fedorenko, Alisa and Bayati, Rozhin and Döring, Patricia and Gerhardt, Maximilian and Strohmeyer, Carolin and Gutiérrez-Gutiérrez, Oscar and Javanmardi, Behnam and Gaubert, Marianne and Kaygusuz, Emrah and Krawitz, Peter and Ueffing, Marius and Hoerauf, Hans and Feltgen, Nicolas and Michalakis, Stylianos and Büning, Hildegard and Cyganek, Lukas and Wollnik, Bernd},
title = {InsightRP2—An Interdisciplinary Approach Toward Therapy Development in RP2 -Associated Retinopathy},
journal = {Human Gene Therapy},
year = {2026},
volume = {37},
number = {23-24},
pages = {1079--1085},
doi = {10.1177/10430342261480906}
}
EUVIMED